Screening for prostatic cancer and its evolution within Britain | Zendy

Parkinson M. C. | Zendy; Bott S. R. J. | Zendy; Montironi R. | Zendy; Melia J. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Screening for prostatic cancer and its evolution within Britain

Author(s) -

Parkinson M. C.,

Bott S. R. J.,

Montironi R.,

Melia J.

Publication year - 2002

Publication title -

the journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.964

H-Index - 184

eISSN - 1096-9896

pISSN - 0022-3417

DOI - 10.1002/path.1088

Subject(s) - prostate cancer , workload , cancer , medicine , gynecology , cancer detection , prostate , histopathology , prostate cancer screening , prostate specific antigen , pathology , computer science , operating system

The arguments for and against screening for prostatic cancer are frequently discussed (Albertsen PC. Screening for prostate cancer is neither appropriate nor cost‐effective. Urol Clin North Am 1996; 23 : 521–530; Schroder FH, Alexander FE, Bangma CH, Hugosson J, Smith DS. Screening and early detection of prostate cancer. Prostate 2000; 44 : 255–263). In contrast, this paper outlines how screening became possible, why the decision was made not to initiate a national screening programme in Britain, the other pathways being pursued, and the current problems, in particular the issue of histopathology workload. Copyright © 2002 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research